Head to Head Comparison: Health Catalyst (NASDAQ:HCAT) & Nexxen International (NASDAQ:NEXN)

Health Catalyst (NASDAQ:HCATGet Free Report) and Nexxen International (NASDAQ:NEXNGet Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations.

Risk and Volatility

Health Catalyst has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, Nexxen International has a beta of 1.86, meaning that its share price is 86% more volatile than the S&P 500.

Profitability

This table compares Health Catalyst and Nexxen International’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Health Catalyst -28.87% -9.38% -4.90%
Nexxen International -0.57% 5.92% 3.68%

Institutional & Insider Ownership

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 54.2% of Nexxen International shares are held by institutional investors. 2.5% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Health Catalyst and Nexxen International”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Health Catalyst $295.94 million 1.57 -$118.15 million ($1.50) -5.11
Nexxen International $331.99 million 1.61 -$21.49 million ($0.07) -113.41

Nexxen International has higher revenue and earnings than Health Catalyst. Nexxen International is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and target prices for Health Catalyst and Nexxen International, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst 0 4 8 0 2.67
Nexxen International 0 1 4 0 2.80

Health Catalyst presently has a consensus target price of $11.58, suggesting a potential upside of 51.22%. Nexxen International has a consensus target price of $9.10, suggesting a potential upside of 14.61%. Given Health Catalyst’s higher possible upside, analysts clearly believe Health Catalyst is more favorable than Nexxen International.

Summary

Nexxen International beats Health Catalyst on 9 of the 14 factors compared between the two stocks.

About Health Catalyst

(Get Free Report)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

About Nexxen International

(Get Free Report)

Nexxen International Ltd. provides end-to-end software platform that enables advertisers to reach publishers Israel. The company’s demand side platform (DSP) offers full-service and self-managed marketplace access to advertisers and agencies to execute their digital marketing campaigns in real time across various ad formats. Its sell supply side platform (SSP) provides access to data and a comprehensive product suite to drive inventory management and revenue optimization. The company also offers data management platform solution, which integrates DSP and SSP solutions enabling advertisers and publishers to use data from various sources in order to optimize results of their advertising campaigns. It serves ad buyers, advertisers, brands, agencies, and digital publishers in the United States, the Asia-Pacific, Europe, the Middle East, and Africa. The company was formerly known as Tremor International Ltd and changed its name to Nexxen International Ltd. in January 2024. Nexxen International Ltd. was incorporated in 2007 and is headquartered in Tel Aviv-Yafo, Israel.

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.